Literature DB >> 19443421

Quality of life assessment after percutaneous aortic valve implantation.

Gian Paolo Ussia1, Massimiliano Mulè, Marco Barbanti, Valeria Cammalleri, Marilena Scarabelli, Sebastiano Immè, Davide Capodanno, Saverio Ciriminna, Corrado Tamburino.   

Abstract

AIMS: To assess the NYHA class and the quality of life (QoL) scores after percutaneous aortic valve implantation (PAVI) with the 18-Fr CoreValve prosthesis. METHODS AND
RESULTS: From April 2007 until August 2008, 57 consecutive patients with aortic stenosis were evaluated for PAVI. Of these, 30 patients with successfully prosthesis implantation had more than 5-month follow-up. QoL assessment was realized with the SF-12v2 Health-Survey, a simple questionnaire designed for self-administration that provides easily interpretable scales for physical [physical component summary (PCS)] and mental [mental component summary (MCS)] health. The questionnaire was administered before and 5 months after PAVI. All 30 patients had a marked upgrading in haemodynamic and echocardiographic parameters (peak-to-peak gradient from 64 +/- 23 to 2 +/- 0.4; P < 0.001; aortic valve area index from 0.3 +/- 0.1 to 0.9 +/- 0.3; P < 0.001), with an improvement in New York Heart Association (NYHA) class at discharge and after 5 months. Mean pre-operative SF-12v2 scores showed a severe impairment of perceived quality of life compared with general Italian population >75 years, both for physical (PCS-baseline 28.5 vs. 37.9, P < 0.001) and mental scores (MCS-baseline 37.8 vs. 45.4, P < 0.001). After 5 months, a striking improvement in both scores (PCS 41.3-MCS 48.3; P < 0.001) was observed.
CONCLUSION: Our preliminary results show a marked short-term improvement in functional status and physical and mental health in patients underwent PAVI.

Entities:  

Mesh:

Year:  2009        PMID: 19443421     DOI: 10.1093/eurheartj/ehp171

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  10 in total

Review 1.  Clinical trial experience with transcatheter aortic valve insertion.

Authors:  Thomas J Helton; Samir R Kapadia; E Murat Tuzcu
Journal:  Int J Cardiovasc Imaging       Date:  2011-02-20       Impact factor: 2.357

Review 2.  TAVI 2012: state of the art.

Authors:  Jochen Reinöhl; Constantin von Zur Mühlen; Martin Moser; Stefan Sorg; Christoph Bode; Manfred Zehender
Journal:  J Thromb Thrombolysis       Date:  2013-05       Impact factor: 2.300

Review 3.  Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: an updated review of literature.

Authors:  Saurav Chatterjee; Dharam Jaydeep Kumbhani; Partha Sardar; Anasua Chakraborty; Giuseppe Biondi-Zoccai; Manpreet Singh Sabharwal; Richard Ro; Balaji Pratap; Chirag P Bavishi; Sripal Bangalore
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

4.  Changing nature of cardiac interventions in older adults.

Authors:  John A Dodson; Mathew S Maurer
Journal:  Aging health       Date:  2011-04

Review 5.  Transcatheter aortic valve implantation: current and future approaches.

Authors:  Josep Rodés-Cabau
Journal:  Nat Rev Cardiol       Date:  2011-11-15       Impact factor: 32.419

Review 6.  New conduction abnormalities after TAVI--frequency and causes.

Authors:  Robert M van der Boon; Rutger-Jan Nuis; Nicolas M Van Mieghem; Luc Jordaens; Josep Rodés-Cabau; Ron T van Domburg; Patrick W Serruys; Robert H Anderson; Peter P T de Jaegere
Journal:  Nat Rev Cardiol       Date:  2012-05-01       Impact factor: 32.419

Review 7.  Transcatheter aortic valve implantation in the elderly: who to refer?

Authors:  Matthew Finn; Philip Green
Journal:  Prog Cardiovasc Dis       Date:  2014-08-12       Impact factor: 8.194

8.  Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium.

Authors:  Martin B Leon; Nicolo Piazza; Eugenia Nikolsky; Eugene H Blackstone; Donald E Cutlip; Arie Pieter Kappetein; Mitchell W Krucoff; Michael Mack; Roxana Mehran; Craig Miller; Marie-Angèle Morel; John Petersen; Jeffrey J Popma; Johanna J M Takkenberg; Alec Vahanian; Gerrit-Anne van Es; Pascal Vranckx; John G Webb; Stephan Windecker; Patrick W Serruys
Journal:  Eur Heart J       Date:  2011-01-06       Impact factor: 29.983

Review 9.  Beyond adding years to life: health-related quality-of-life and functional outcomes in patients with severe aortic valve stenosis at high surgical risk undergoing transcatheter aortic valve replacement.

Authors:  Marcus-Andre Deutsch; Sabine Bleiziffer; Yacine Elhmidi; Nicolo Piazza; Bernhard Voss; Ruediger Lange; Markus Krane
Journal:  Curr Cardiol Rev       Date:  2013-11

10.  Change in quality of life after transcatheter aortic valve implantation and aortic valve replacement surgery in Australian patients aged ≥ 75 years: the effects of EuroSCORE and patient operability.

Authors:  Phillip J Tully; Prakash Roshan; Greg D Rice; Ajay Sinhal; Jayme S Bennetts; Robert A Baker
Journal:  J Geriatr Cardiol       Date:  2015-01       Impact factor: 3.327

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.